Continue to Site

Roche enters red-hot metabolic disease market with Carmot Therapeutics acquisition

Novo Nordisk

Novo Nordisk to boost GLP-1 capacity with €2.1 billion investment in France

This is a portrait hoto of President Joe Biden who has a new plan to boost the U.S. supply chain for pharmaceuticals and other products.

Biden’s supply chain plans include made-in-America medicines

Pfizer logo

Pfizer restructuring push hits Ireland

Multi Color DNA Structure On Black Backdrop Generative AI

Forecast 2024: Pharma industry grapples with regulatory hurdles and AI opportunities


Senators urge action on Beyfortus supply as RSV threat looms

Compliance concept with icons and text. Regulations, law, standards, requirements, audit diagram on virtual screen.

Navigating the new regulatory terrain pharma companies face with IRA and 340B


AstraZeneca faces profitability dip in Q3 2023 despite revenue bump; bets big on obesity


Commitment to operational efficiency and partnerships yield dividends for Teva